Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV +2.72%88 EV-to-EBIT is 28.47 as of Aug. 05, 2026, which is 57% below its 10-year median of 65.75. GuruFocus rates VEEV with a GF Score™ of 88/100 and a GF Value™ of $290.61 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 470 Healthcare Providers & Services companies, Veeva Systems ranks worse than 74.68% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Veeva Systems's Enterprise Value for the quarter that ended in Apr. 2026 was $18,205 Mil.
Veeva Systems's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $956 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems EV-to-EBIT Related Terms
Veeva Systems EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Veeva Systems's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Veeva Systems's EV-to-EBIT falls into.
Veeva Systems's current Enterprise Value is $27,206 Mil.
Veeva Systems's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $956 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a EV-to-EBIT of 28.47 as of Aug. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Veeva Systems and its competitors. This is 57% below median its historical median of 65.75. Over the past decade, Veeva Systems' EV-to-EBIT has ranged from 19.08 to 174.55. According to the industry distribution chart, Veeva Systems ranks #351 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 74.7%.
Is Veeva Systems' EV-to-EBIT too high?
Veeva Systems' current EV-to-EBIT of 28.47 is 57% below median its 10-year median of 65.75. Over the past 10 years, this metric has ranged from a low of 19.08 to a high of 174.55. The Healthcare Providers & Services industry median EV-to-EBIT is 15.99. Veeva Systems' value of 28.47 is 78.1% above this industry median. Based on the distribution chart, Veeva Systems ranks #351 out of 470 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Veeva Systems has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' EV-to-EBIT compare to BTSG and HQY?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #351 out of 470 companies for EV-to-EBIT. This places Veeva Systems in the lower half of its industry. The industry median EV-to-EBIT is 15.99. Veeva Systems' value of 28.47 is 78.1% above this benchmark. Historically, Veeva Systems' own EV-to-EBIT has ranged from 19.08 to 174.55 over the past decade. While the company's 10-year median is 65.75 vs. the industry median of 15.99, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.99, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current EV-to-EBIT of 28.47 is 78.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current EV-to-EBIT is 28.47, which is 57% below median its own 10-year median of 65.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Modestly Undervalued. The stock's GF Value™ is $290.61, compared to a current price of $211.86 — trading 27.1% below its estimated fair value. The current EV-to-EBIT is 28.47, which is 57% below median its 10-year median of 65.75 and 78.1% above the Healthcare Providers & Services industry median of 15.99. Veeva Systems' overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Veeva Systems (VEEV), the current EV-to-EBIT is 28.47 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $211.86 is trading 27.1% below its estimated GF Value™ of $290.61.
GuruFocus considers Veeva Systems to be Modestly Undervalued.
Key valuation signals for VEEV:
EV-to-EBIT: 28.47 (57% below median its 10-year median of 65.75)
GF Value™: $290.61 vs. price of $211.86 (27.1% below fair value)
Industry Position: 78.1% above the Healthcare Providers & Services median (#351 of 470)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
88GF Score
Get the complete analysis for VEEV
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
